Dear Colleagues,

We are pleased to announce the “Antibiotics 2024 Best Paper Award” for research and review articles published in Antibiotics from 1 January 2022 to 31 December 2022. One review and one research article will each receive an award. The papers will be selected after a thorough evaluation by the journal’s Award Committee, led by its Editor-in-Chief, Prof. Dr. Nicholas Dixon, and the winners will be announced in March 2024.

Eligibility for the Award:
– Papers published in Antibiotics from 1 January 2022 to 31 December 2022;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.

Selection Criteria:
The papers will be selected by the journal’s Award Committee according to the following criteria:
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.

Prizes:
– One review award: CHF 500 and a chance to publish a free paper in Antibiotics till the end of 2025;
– One research article award: CHF 500 and a chance to publish a free paper in Antibiotics till the end of 2025;
– Each winner will also receive an electronic certificate.

The winners will be announced on the journal’s website at the end of March 2024.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

On behalf of the Editor-in-Chief, Prof. Dr. Nicholas Dixon, we would like to acknowledge our reviewers who generously devote their time to reviewing the papers submitted to Antibiotics, by presenting an award to the reviewers who have demonstrated their dedication, professionalism, and timeliness in reviewing manuscripts for Antibiotics.

What are the pre-requisites to be eligible for this award?
All of the reviewers for Antibiotics in 2023 will be automatically included.

Selection criteria:
– Number of review reports;
– The quality and timeliness of review reports.

What will the winners receive?
Three winners will each receive the following:
– CHF 500;
– An opportunity to publish a paper free of charge in 2024 after peer review;
– A certificate.

When will the winners be announced?
The winners will be announced on the journal website at the end of February 2024.

How can I make myself eligible?
If you have not yet reviewed papers for Antibiotics, but would like to do so, you can register as a reviewer via the following link: https://susy.mdpi.com/volunteer/profile/edit.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

We are pleased to announce the winners of the Antibiotics 2023 Best Paper Award. All of the papers published in 2021 in Antibiotics were considered for the award. After a thorough evaluation of the originality as well as significance of the papers, citations, and downloads, the two winning papers, which were nominated by the journal’s Award Committee, have been selected.

pH-Responsive “Smart” Hydrogel for Controlled Delivery of Silver Nanoparticles to Infected Wounds
By Hanif Haidari, Zlatko Kopecki, Adam T. Sutton, Sanjay Garg, Allison J. Cowin and Krasimir Vasilev
Antibiotics 2021, 10(1), 49

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions
By Loukas Kakoullis, Eleni Papachristodoulou, Paraskevi Chra and George Panos
Antibiotics 2021, 10(4), 415

Each winner will receive CHF 500 and a chance to publish a free paper in Antibiotics till the end of 2024. We believe the above papers represent valuable contributions to Antibiotics and the scientific literature. We warmly congratulate the winners.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

We are pleased to announce the winners of the Antibiotics 2022 Outstanding Reviewer Award. The Antibiotics Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Antibiotics. It is due to their efforts that the high quality of the journal and quick turnaround are maintained.

Dr. Maxime Pichon
Laboratoire de Bactériologie-Hygiène, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
Research Interest: bacterial infection; infectiology; microbiome; diagnosis; antibiotic resistance

Dr. Violeta Popovici
Department of Microbiology and Immunology, Ovidius University of Constanta, Constanta, Romania
Research Interest: plant/lichen secondary metabolites - identification and pharmacological potential; antibiotics; antimicrobial activity; in vitro anticancer activity; oral cancer; ROS, oxidative stress, antioxidants/prooxidants.

Dr. Yosra A. Helmy
Department of Veterinary Science, University of Kentucky, Lexington, USA
Research Interest: Foodborne Pathogen; public health and zoonoses; antimicrobial development; campylobacteriosis; salmonellosis; drug development; cryptosporidium; giardia; E.coli; antimicrobial resistance

The Prize for Each Winner:
• CHF 500 (Swiss francs);
• An electronic certificate.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

We are pleased to announce the winners of the Antibiotics 2022 Best Paper Award. All of the papers published in 2020 in Antibiotics were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, the two winning papers, which were nominated by the Editor-in-Chief, Prof. Dr. Nicholas Dixon, have been selected.

Review:
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
By Charles H. Chen and Timothy K. Lu
Antibiotics 2020, 9(1), 24; doi:10.3390/antibiotics9010024.

Research article:
Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries
By Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar, Dik Mevius and Jeroen Dewulf
Antibiotics 2020, 9(2), 87; doi:10.3390/antibiotics9020087.

Each winner (corresponding author) will receive CHF 500 (Swiss francs), an electronic certificate, and a chance to publish a free paper in Antibiotics in 2023.

On behalf of the Assessment Committee, I congratulate the winners on their accomplishments. We would like to take this opportunity to thank all of the nominated research groups of the above exceptional papers for their contributions to Antibiotics as well as thank the Award Committee for voting and helping with this award.

Editor-in-Chief
Prof. Dr. Nicholas Dixon, Antibiotics

Dear Colleagues,

On behalf of the award committee, it is our pleasure to announce the winners of the Antibiotics 2022 Travel Award.

The award has been granted to:

Dr. Filip Jansåker, a post-doctoral fellow at Center for Primary Healthcare Research, Department of Clinical Medicine, Lund University, Lund, Sweden.

Dr. Vanessa Silva, a Ph.D. student at Verinary Sciences Department, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal.

Each of the winners will receive CHF 800 (Swiss francs) and an electronic certificate.

With the numerous high-quality applicants considered for this award, there were challenges faced in the evaluation process and in making the final decision. We would like to thank all the applicants for submitting diverse and fascinating range of research topics. On behalf of the assessment committee, we congratulate the winners on their accomplishments.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

As the Editor-in-Chief of Antibiotics, it is my great pleasure to announce the winner of the Antibiotics 2021 Ph.D. Thesis Award. This prize was aimed to be granted to a Ph.D. student or a doctor who has produced a highly anticipated academic potential thesis.

The award has been granted to:

“Design & Synthesis of Peptidomimetics as Toolbox to Probe Emerging Antimicrobial and Anticancer Strategies” By Rosa Bellavita, Department of Pharmacy, University of Naples, Federico II., Naples, Italy.

The winner will receive CHF 1000, an electronic certificate, and the opportunity to publish a free paper in Antibiotics in 2022.

On behalf of the evaluation committee, I congratulate Dr. Rosa Bellavita on her accomplishments. We would like to take this opportunity to thank all the nominated research groups of the above exceptional thesis for their contributions to Antibiotics, and thank the Awards Committee for voting and helping with this award.

Prof. Dr. Nicholas Dixon
Editor-in-Chief, Antibiotics

We are pleased to announce the winners of the Antibiotics 2021 Best Paper Awards. All papers published in 2019 in Antibiotics were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, the two winning papers, which were nominated by the journal Award Committee, have been selected.

Antimicrobial and Synergistic Effects of Commercial Piperine and Piperlongumine in Combination with Conventional Antimicrobials
By Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm
Antibiotics 2019, 8(2), 55

Antibiotic Discovery: Where Have We Come from, Where Do We Go?
By Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado
Antibiotics 2019, 8(2), 45

Each winner will receive 500 CHF and the opportunity to publish one paper with 50% discount in Antibiotics in 2021. We believe the above papers represent valuable contributions to Antibiotics and the scientific literature. We warmly congratulate the winners.

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

We are pleased to announce the winners of the Antibiotics 2020 Outstanding Reviewer Award. The Antibiotics Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to Antibiotics. It is due to their efforts that the high quality of the journal and quick turnaround is maintained.

Jean Vanderpas
Consultant Ecole Santé Publique, Université Libre de Bruxelles, Bruxelles, Belgium
Research Interest: Infectious Disease Surveillance; Epidemiological Analysis; Clinical Epidemiology; Epidemiological Statistics; Infectious Disease Epidemiology; Selenium; Vaccines; Metabolites; Rabies Vaccines

Morgan Feeney
Strathclyde Institute Of Pharmacy And Biomedical Sciences, University of Strathclyde, Glasgow, UK
Research Interest: oxidative stress; antibiotics; Streptomyces; bacterial genetics; suppressor analysis

Kind regards,
Antibiotics Editorial Office

Dear Colleagues,

We are pleased to announce that the winner of the Antibiotics 2020 Young Investigator Award is Dr. Cesar de la Fuente.

Dr. Cesar de la Fuente is the Presidential Assistant Professor at the University of Pennsylvania. He is a leader of his generation of computational and synthetic biologists pushing the frontiers of antibiotic discovery. His out-of-the-box work is having a profound impact on the design and synthesis of antimicrobial medicines and on the field of infectious diseases as a whole. Dr. Cesar de la Fuente received his PhD in 2014 and has an outstanding publication record, comprising 91 publications in peer-reviewed international journals and over 10 international patents. His Scopus Scientific Citations number is 4600, and his Hirsch index is 31. He is clearly a rising star in the field of antibiotic discovery, microbiology, synthetic biology, computational biology, and infectious diseases. He has received substantial funding for his independent work and is also an active and leading entrepreneur, and some of his patents involving the use of synthetic peptides for the treatment of infectious diseases have been licensed to a number of companies and are currently under development. Please join us in congratulating Dr. Cesar de la Fuente for his outstanding achievements.

As the awardee, Dr. Cesar de la Fuente will receive an honorarium of CHF 2000, an offer to publish a paper free of charge before the end of December 2021 in Antibiotics after peer review, and an engraved plaque.

We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.

Antibiotics 2020 Young Investigator Evaluation Committee

Dear Colleagues,

As the Chair of the Travel Awards Evaluation Committee, I am pleased to announce the winner of the 2019 Antibiotics Travel Award.

The Evaluation Committee were very impressed with the high level of work presented, and after careful consideration, the Travel Award have been granted to Mr. Damien Cabral, a Ph.D. student at Brown University, Providence, RI, USA, who is working on characterizing the functional response of the gut microbiome to antibiotic therapy.

The winner will receive 800 Swiss Francs to be used to attend and participate at any academic conference in 2019.

It is also our pleasure to announce that as part of the reward, Antibiotics will offer the Top 10 candidates the opportunity to publish a paper with the publication fees waived. We would like to thank all applicants for their participation and interest in our journal.

We also thank our Evaluation Committee members, Drs. Gary A. Strobel, Patrice Courvalin and William M. Shafer, for their comprehensive evaluation of the candidates.

Prof. Dr. Jeffrey Lipman
Chair of the Evaluation Committee

Dear Colleagues,

As Editor-in-Chief of Antibiotics, I am pleased to announce the winners of the 2017 Antibiotics Travel Awards. The Evaluation Committee were very impressed with the high level of work presented and, after careful consideration, the two Travel Awards have been granted to Dr. Bimal Jana, a postdoctoral fellow at Ross University, Basseterre, St. Kitts, for his work on identifying chromosomal non-essential genes that are essential for MDR Klebsiella pneumoniae ST258 under the presence of therapeutically relevant concentrations of antimicrobial; and to Vera Pader, a Ph.D. student at Imperial College London, London, UK, working on the link between antibiotic resistance and virulence in Staphylococcus aureus.

The awards consist of 800 Swiss Francs each, and are available for the winners to use for attendance and participation in any academic conferences in 2017.

It is also our pleasure to announce that as part of the reward, Antibiotics will offer the Top 35 candidates the opportunity to publish a paper with the publication fees waived. We would like to thank all applicants for their participation and interest in our journal.

We would also like to deliver our great thanks to the Evaluation Committee members, Drs. Andrei L. Gartel, Gary A. Strobel, Gian Maria Rossolini, Jeffrey Lipman, Leonard Amaral, Morten Lindbæk, Nora Vazquez-Laslop, Patrice Courvalin, William M. Shafer and Ying Zhang, for their comprehensive evaluation of candidates.

Prof. Dr. Christopher C. Butler
Editor-in-Chief